Claudin-5 is associated with elevated TATI and CA125 levels in mucinous ovarian borderline tumors

Anticancer Research

Volumn 35, Issue 2, 2015, Pages 973-976

  Nissi, Ritva ^a   Talvensaari Mattila, Anne ^a   Kuvaja, Paula ^a,b   Pääkkö, Paavo ^a   Soini, Ylermi ^c   Santala, Markku ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

CA 125; Claudin; Ovarian mucinous borderline tumor; TATI

Indexed keywords

APROTININ; CA 125 ANTIGEN; CLAUDIN 5; TUMOR ASSOCIATED TRYPSIN INHIBITOR 1; UNCLASSIFIED DRUG; CLDN5 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ASCITES; BRENNER TUMOR; CANCER SURGERY; CLINICAL ARTICLE; ENDOCERVICAL MUCINOUS BORDERLINE TUMOR; FEMALE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCINOUS BORDERLINE TUMOR; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMALL INTRAEPITHELIAL FOCUS OF CARCINOMA; VERY ELDERLY; COLLOID CARCINOMA; METABOLISM; MIDDLE AGED; OVARY TUMOR; PHYSIOLOGY; YOUNG ADULT;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; CLAUDIN-5; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; TRYPSIN INHIBITOR, KAZAL PANCREATIC; YOUNG ADULT;

EID: 84923666760     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Turksen K and Troy T-C: Barriers built on claudins. J Cell Science 117: 2435-2447, 2004.
2. Martin TA and Jiang WG: Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta 1788: 872-891, 2009.
3. Soini Y: Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology 46: 551-560, 2005.
4. Van Itallie CM and Anderson JM: Claudin interactions in and out of the tight junction Tissue Barries 1: e25249, 2014
5. International Federation of Gynecology and Obstetrics Classification and staging of malignant tumors in the female pelvis: Acta Obstet Gynecol Scand 150: 1-7, 1971.
6. Hoskins PJ: Ovarian tumors of low malignant potential: borderline epithelial ovarian carcinoma. In: Lawton FG, Neijt JP, Swenerton KD (eds.). Epithelial cancer of the ovary. London: BMJ Publishing Group., pp. 112-136. 2005.
7. Dahiya N, Becker KG and Wood WH: Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasion. PLoS One 6: e22119, 2011.
8. Jia W, Lu R, Martin TA and Jian WG: The role of claudin-5 in blood-brain barrier and brain metastases. Mol Med Rep 9: 779-785, 2014.
9. Soini Y, Eskelinen M, Juvonen P, Kärjä V, Haapasaari KM, Saarela A and Karihtala P: Strong claudin 5 expression is a poor prognostic sign in pancreatic adenocarcinoma. Tumour Biol 35: 3803-3808, 2014.
10. Escudero-Esparza A, Jiang WG and Martin TA: Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways. J Exp Clin Cancer Res 43: 31-34, 2012.
11. Soini Y, Talvensaari-Mattila A. Expression of claudins 1, 4, 5, and 7 in ovarian tumors of diverse types. Int J Gyn Pathol 25: 330-335, 2006.
12. Turunen M, Talvensaari-Mattila A and Soini Y: Claudin-5 overexpression correlates with aggressive behaviour in serous ovarian adenocarcinoma. Anticancer Res 29: 5185-5190, 2009.
13. Koda R, Zhao L and Yaoita E: Novel expression of claudin-5 in glomerular podocytes. Cell Tissue Res 343: 637-648, 2011.
14. Markov AG, Voronkova MA and Volgin GN: Tight junction proteins contribute to barrier properties in human pleura. Respir Physiol Neurobiol 175: 331-335, 2011.
15. Wang Q, Zheng JY and Kreth J. Regulation of prostate-specific antigen expression by the junctional adhesion molecule A. Urology 73: 1119-1125, 2009.
16. Zheng JY, Yu D and Foroohar M. Regulation of the expression of the prostate-specific antigen by claudin-7. J Membr Biol 194: 187-197, 2003.
17. Ding L, Lu Z and Foreman O: Inflammation and disruption of the mucosal architecture in claudin-7-deficient mice. Gastroenterology 142: 305-315, 2012.
18. Hata M, Yamanegi K, Yamada N, Ohyama H, Ykitatsu Y, Nakasho K, Okamura H and Terada N: Estrogen decreases the expression of claudin-5 in vascular endothelial cells in the murine uterus. Endocr J 61: 705-715, 2014.
19. Kashiwamura Y, Sano Y and Abe M: Hydrocortisone enhances the function of the blood-nerve barrier through the up-regulation of claudin-5. Neurochem Res 36: 849-955, 2011.